The Subject Expert Committee (SEC) has approved the Phase -3 trial data of Bharat Biotech's Covaxin that was performed on 25,800 subjects.
Indian Industrial Value Chain Collective (IIVCC), a group representing organizations involved in the industrial production and consumption supply ...
Worldwide, the pharma industry has undergone a quick change over the last year, with the demand generated from the COVID pandemic overriding other ...
India began buying prompt shipments of liquefied natural gas from the spot market after a two-mon...
JSW Cement, a part of USD 12 billion JSW Group, on Monday proclaimed its venture into ready mix c...
We use cookies to ensure you get the best experience on our website. Read more...